63 related articles for article (PubMed ID: 18797626)
1. Access to medicines versus access to treatment: the case of type 1 diabetes.
Beran D; McCabe A; Yudkin JS
Bull World Health Organ; 2008 Aug; 86(8):648-9. PubMed ID: 18797626
[No Abstract] [Full Text] [Related]
2. Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil.
Nunn A; Fonseca ED; Gruskin S
Glob Public Health; 2009; 4(2):131-49. PubMed ID: 19333805
[TBL] [Abstract][Full Text] [Related]
3. Associations between essential medicines and health outcomes for cardiovascular disease.
Steiner L; Fraser S; Maraj D; Persaud N
BMC Cardiovasc Disord; 2021 Mar; 21(1):151. PubMed ID: 33765933
[TBL] [Abstract][Full Text] [Related]
4. Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries.
Bazargani YT; Ugurlu M; de Boer A; Leufkens HGM; Mantel-Teeuwisse AK
BMC Cardiovasc Disord; 2018 Jun; 18(1):126. PubMed ID: 29940880
[TBL] [Abstract][Full Text] [Related]
5. Availability, cost and affordability of essential medicines for chronic respiratory diseases in low-income and middle-income countries: a cross-sectional study.
Stolbrink M; Ozoh OB; Halpin DMG; Nightingale R; Meghji J; Plum C; Allwood BW; Jayasooriya S; Mortimer K;
Thorax; 2024 Jun; 79(7):676-679. PubMed ID: 38760170
[TBL] [Abstract][Full Text] [Related]
6. Essential medicines for universal health coverage.
Wirtz VJ; Hogerzeil HV; Gray AL; Bigdeli M; de Joncheere CP; Ewen MA; Gyansa-Lutterodt M; Jing S; Luiza VL; Mbindyo RM; Möller H; Moucheraud C; Pécoul B; Rägo L; Rashidian A; Ross-Degnan D; Stephens PN; Teerawattananon Y; 't Hoen EF; Wagner AK; Yadav P; Reich MR
Lancet; 2017 Jan; 389(10067):403-476. PubMed ID: 27832874
[No Abstract] [Full Text] [Related]
7. Lack of access to insulin: undermining the Rights of the Child.
Heller O; Duperrex O; Jaffé PD; Goldhagen J; Abidha CA; Skelton A; Otani M; Heller Y; Vassalli JD; Beran D
Lancet Diabetes Endocrinol; 2024 Jul; 12(7):444-445. PubMed ID: 38824930
[No Abstract] [Full Text] [Related]
8. Inflation, Economic Policy Changes, and Access to Essential Drugs by Retirees in Argentina.
Macchia A; Mariani JA; Tognoni G
JAMA Netw Open; 2024 Jun; 7(6):e2415929. PubMed ID: 38857051
[TBL] [Abstract][Full Text] [Related]
9. Health-industry linkages for local health: reframing policies for African health system strengthening.
Mackintosh M; Mugwagwa J; Banda G; Tibandebage P; Tunguhole J; Wangwe S; Karimi Njeru M
Health Policy Plan; 2018 May; 33(4):602-610. PubMed ID: 29562286
[TBL] [Abstract][Full Text] [Related]
10. On Patient Safety: Mirroring the Strategies Used for Delivering COVID-19 Medications May Improve How Developing Countries Obtain Essential Medicines.
Rickert J
Clin Orthop Relat Res; 2021 Feb; 479(2):236-238. PubMed ID: 33273246
[No Abstract] [Full Text] [Related]
11. Essential medicines and access to insulin.
Gill G; Yudkin JS; Tesfaye S; de Courten M; Gale E; Motala A; Ramaiya K; Unwin N; Wild S
Lancet Diabetes Endocrinol; 2017 May; 5(5):324-325. PubMed ID: 28330591
[No Abstract] [Full Text] [Related]
12. Morality and Access to Essential Medicines: Pairing the Theoretical and Practical.
Da Silva M; Albertsen A
Dev World Bioeth; 2024 Mar; 24(1):3-5. PubMed ID: 38328880
[No Abstract] [Full Text] [Related]
13. [Methods for measuring the suitability of pharmacological treatment in the elderly with multiple conditions and on multiple drugs].
Buitrago Ramírez F
Aten Primaria; 2013 Jan; 45(1):19-20. PubMed ID: 23177389
[No Abstract] [Full Text] [Related]
14. Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review.
Castillo-Laborde C; Hirmas-Adauy M; Matute I; Jasmen A; Urrejola O; Molina X; Awad C; Frey-Moreno C; Pumarino-Lira S; Descalzi-Rojas F; Ruiz TJ; Plass B
Public Health Rev; 2022; 43():1604796. PubMed ID: 36120091
[No Abstract] [Full Text] [Related]
15. Optimizing diabetes mellitus care to improve COVID-19 outcomes in resource-limited settings in Africa.
Kyazze AP; Bongomin F; Ninsiima S; Nattabi G; Nabakka W; Kukunda R; Odanga H; Ssekamatte P; Baluku JB; Kibirige D; Andia-Biraro I
Ther Adv Infect Dis; 2021; 8():20499361211009380. PubMed ID: 33996072
[TBL] [Abstract][Full Text] [Related]
16. Mitigating The Burden Of Diabetes In Sub-Saharan Africa Through An Integrated Diagonal Health Systems Approach.
Mercer T; Chang AC; Fischer L; Gardner A; Kerubo I; Tran DN; Laktabai J; Pastakia S
Diabetes Metab Syndr Obes; 2019; 12():2261-2272. PubMed ID: 31802925
[TBL] [Abstract][Full Text] [Related]
17. Ensuring Patient-Centered Access to Cardiovascular Disease Medicines in Low-Income and Middle-Income Countries Through Health-System Strengthening.
Tran DN; Njuguna B; Mercer T; Manji I; Fischer L; Lieberman M; Pastakia SD
Cardiol Clin; 2017 Feb; 35(1):125-134. PubMed ID: 27886782
[TBL] [Abstract][Full Text] [Related]
18. Managing non-communicable diseases at health district level in Cambodia: a systems analysis and suggestions for improvement.
Jacobs B; Hill P; Bigdeli M; Men C
BMC Health Serv Res; 2016 Jan; 16():32. PubMed ID: 26818827
[TBL] [Abstract][Full Text] [Related]
19. Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings.
Beran D; Miranda JJ; Cardenas MK; Bigdeli M
Health Res Policy Syst; 2015 Oct; 13():41. PubMed ID: 26427953
[TBL] [Abstract][Full Text] [Related]
20. Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.
Sarayani A; Rashidian A; Gholami K
BMJ Open; 2014 Oct; 4(10):e005859. PubMed ID: 25324322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
